Cognex M&A head sells 61,900 shares after exercises
COGNEX CORP executive Joerg Kuechen reported option and RSU exercises alongside significant share sales.
Rhea-AI Filing Summary
COGNEX CORP executive Joerg Kuechen reported option and RSU exercises alongside significant share sales. On February 20–21, 2026, he exercised multiple non-qualified stock options and restricted stock units, receiving Cognex common stock through derivative exercises at stated exercise prices such as $33.04, $38.39, and $39.44 per share.
He then sold a total of 61,900 shares of common stock in open-market transactions at prices around $55.98–$56.24, and some additional shares were disposed of to satisfy tax withholding obligations on vested restricted stock units, as described in the footnotes. After these transactions, Kuechen directly owned 6,032 shares of Cognex common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
25 txns
Insider
Kuechen Joerg
Role
Head of Corporate M&A
Sold
61,900 shs ($3.47M)
Approx. gross sale proceeds
$3.47M
Approx. exercise cost
$2.25M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 6,355 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,355 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,073 | $56.03 | $172K |
| Exercise | Non-Qualified Stock Option (right to buy) | 11,029 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 12,500 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 35,642 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 5,325 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,029 | $33.04 | $364K |
| Sale | Common Stock | 11,029 | $55.9801 | $617K |
| Exercise | Common Stock | 12,500 | $38.39 | $480K |
| Sale | Common Stock | 12,500 | $56.0322 | $700K |
| Exercise | Common Stock | 35,642 | $39.44 | $1.41M |
| Sale | Common Stock | 35,642 | $56.0322 | $2.00M |
| Sale | Common Stock | 2,729 | $56.2401 | $153K |
| Exercise | Common Stock | 5,325 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,575 | $56.03 | $144K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 439,242 contracts for 341,669 underlying shares (Direct);
Restricted Stock Unit — 33,856 contracts for 24,982 underlying shares (Direct);
Common Stock — 6,032 shares (Direct)
Footnotes (8)
- F1. This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein.
- F2. This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.
- F3. The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
- F4. The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 21, 2017).
- F5. The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024).
- F6. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- F7. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
- F8. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Joerg Kuechen report for COGNEX CORP (CGNX)?
Joerg Kuechen reported exercising multiple stock options and restricted stock units and selling shares of Cognex common stock. The filing shows derivative exercises followed by open-market sales and tax-related share dispositions over February 20–21, 2026.
At what prices were Joerg Kuechen’s Cognex (CGNX) option exercises and sales reported?
Stock options were exercised at prices including $33.04, $38.39, and $39.44 per share. Resulting Cognex common shares were then sold in the market at prices roughly between $55.98 and $56.24 per share, according to the Form 4 data.
What is Joerg Kuechen’s role at Cognex (CGNX) mentioned in the Form 4?
The Form 4 identifies Joerg Kuechen as an officer of Cognex Corporation, holding the title Head of Corporate M&A. The reported equity transactions therefore reflect activity by a senior company executive.
AI-generated analysis. How Rhea-AI works. Not financial advice.
